Besse B, Goto K, Wang Y, Lee SH, et al. Amivantamab Plus Lazertinib in Patients With EGFR-mutant Non-small Cell Lung Cancer (NSCLC) After Progression on Osimertinib and Platinum-based Chemotherapy: Results From CHRYSALIS-2 Cohort A. J Thorac Oncol 2025 Jan 2:S1556-0864(24)02550.
PMID: 39755170